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Abstract: Experiments on reversible and irreversible cell electroporation were 
carried out with an experimental setup based on a standard apparatus for 
horizontal electrophoresis, a syringe pump with regulated cell suspension flow 
velocity and a dcEF power supply. Cells in suspension flowing through an 
orifice in a barrier inserted into the electrophoresis apparatus were exposed to 
defined localized dcEFs in the range of 0-1000 V/cm for a selected duration in 
the range 10-1000 ms. This method permitted the determination of the viability 
of irreversibly electroperforated cells. It also showed that the uptake by 
reversibly electroperforated cells of fluorescent dyes (calcein, 
carboxyfluorescein, Alexa Fluor 488 Phalloidin), which otherwise do not 
penetrate cell membranes, was dependent upon the dcEF strength and duration 
in any given single electrical field exposure. The method yields reproducible 
results, makes it easy to load large volumes of cell suspensions with membrane 
non-penetrating substances, and permits the elimination of irreversibly 
electroporated cells of diameter greater than desired. The results concur with and 
elaborate on those in earlier reports on cell electroporation in commercially 
available electroporators. They proved once more that the observed cell 
perforation does not depend upon the thermal effects of the electric current upon 
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cells. In addition, the method eliminates many of the limitations of commercial 
electroporators and disposable electroporation chambers. It permits the 
optimization of conditions in which reversible and irreversible electroporation 
are separated. Over 90% of reversibly electroporated cells remain viable after 
one short (less than 400 ms) exposure to the localized dcEF. Experiments were 
conducted with the AT-2 cancer prostate cell line, human skin fibroblasts and 
human red blood cells, but they could be run with suspensions of any cell type. It 
is postulated that the described method could be useful for many purposes in 
biotechnology and biomedicine and could help optimize conditions for in vivo 
use of both reversible and irreversible electroporation. 
 
Key words: Irreversible electroporation, Reversible electroporation, Flow 
through electric field, Fluorescent dye loading, Cell viability, Direct current 





Reversible electroporation (RE) is often used to introduce substances into cells, 
such as dyes, drugs, proteins and nucleic acids, which otherwise do not penetrate 
through cell membranes [1-3]. In recent years, increasing attention has been paid 
to irreversible electroporation (IRE), which was found to be an effective technique 
for neoplastic tissue ablation without scar formation or local bleeding [4-8]. 
There is commercially available equipment for electroporation, based on the 
application of electric pulses to cell suspensions or tissues. Its design limits the 
influence of the investigator on the experimental procedure. The amplitude 
(strength), duration and number of electric pulses applied to cells can be modulated 
only in a narrow range, and the disposable chambers for electroporation of cell 
suspensions are usually of low volume (less than 0.5-1 ml) [9-11].  
The experiments presented in this report were carried out in order to develop  
a research-appropriate system that would be free of some of the limitations 
associated with the use of commercially available electroporators and electric 
pulse generators.  
The second goal was to quantitatively examine the efficiency of the developed 
method of cell electroporation, described herein as flow through a localized 
electric field. These measurements focused on confirming and elaborating on 
earlier studies performed using commercial electroporators. It is suggested that 
the described alternative method of cell electroporation facilitates further 
research in this field and could be useful in the search for improved conditions 
of electroporation in vivo, which requires the use of conventional commercial 
electroporators. This method is expected to open new possibilities for broader 
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MATERIAL AND METHODS 
 
Chemicals 
Ethidium bromide, diacetate fluorescein, Alexa Fluor 488 Phalloidin, 
gentamicin, calcein and Trypsin-EDTA were obtained from Sigma. Fetal bovine 
serum (FBS) was purchased from Gibco (Invitrogen). Carboxyfluorescein was 
from Fluka-biochemist (Buchs, Switzerland) and culture medium RPMI 1640 
with L-glutamine from Lonza. PBS-buffered saline without calcium and 
magnesium ions and PBS-buffered saline with calcium and magnesium ions 
were obtained from Biomed, and sucrose from Merck. 
 
Cells 
Experiments were carried out on the well-characterized AT-2 rat prostate cancer 
cell line grown in 25-cm2 flasks (Sarstead) as described previously [12]. For 
some experiments, normal human skin fibroblasts (HSF) were grown in vitro as 
described previously [13]. Human red blood cells isolated from blood drawn 
from healthy laboratory volunteers were also used. Before the electroporation 
experiments, the cells were washed in Ca,Mg-free PBS by centrifugation and 
suspended in an electroporation solution. The electroporation solution, if not 
modified as described in the Results section, was 9.5% sucrose and PBS with 
Ca/Mg ions in the ratio 19:1. 
 
Cell electroporation system 
Cell electroporation was carried out with a setup consisting of a standard EP 
1201-1EA apparatus for horizontal electrophoresis (Sigma-Aldrich, UK), a PS 
304 Electrophoresis Power Supply (Gibco BRL, Life Technologies, USA; not 
shown on the photo), a Type 610 BS Syringe Infusion Pump (Medipan, Warsaw, 
Poland; not shown on the photo), power supply cords with plugs, a silicon 
rubber tube with an inserted 3-cm long segment made of a dialysis tube 1 mm in 
diameter (made from Sigma dialysis tubes), an exchangeable plexiglass barrier 
(1 to 5 mm thick) with an orifice 1 mm in diameter, and probe electrodes 
situated at two sides of the barrier and connected to a Multimeter G-1004.500 
voltmeter (RFT, Germany) to measure the dcEF strength across the barrier. The 
tube was immersed in the same electroporation buffer as the cell suspensions. 
The linear velocity of the cell suspension flow was estimated by dividing the 
volume of the suspension pumped in one second by the diameter of the orifice in 
the barrier. Continuous velocity of the flow was assured by the syringe infusion 
pump – peristaltic pumps are not suitable for this purpose. The duration of cell 
suspension exposure to high dcEFs focused in the segment of the tube passing 
through the barrier orifice was calculated from the known thickness of the 
barrier and the linear velocity of the flow of the cell suspension. 
 
Cell viability examination 
Cell viability was determined using the fluorescein diacetate (FDA) test, which 
is based on the preservation of esterase activity, and the ethidium bromide (Eth Br2) 
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test, which is based on an examination of the maintenance of cell membrane 
integrity [14-17]. The viability of the electroporated cells was examined 15-30 
min after electroporation. In each sample, at least 250 cells were observed and 
counted under an epi-fluorescent microscope (Jenavert, Carl Zeiss Jena, 
Germany). Green fluorescent cells were counted as alive and red fluorescent 
cells as dead or irreversibly electroporated (IRE; Fig. 1). Sporadically, the 
viability of cells loaded with carboxyfluorescein or calcein through 
electroporation was tested by washing in PBS and seeding in culture medium to 
cell culture flasks. Cells attaching to the plastic and actively spreading on its 




Fig. 1. Cell viability examination. A – Fluorescein diacetate/ethidium bromide test of the 
viability of the electroporated AT2 prostate cancer cell line was performed 10 min after 
electroporation. The fluorescent dyes were added on top of the spread cells. Viable cells 
fluoresce green, while dead (irreversibly electroporated) cells fluoresce red. Photos from  
a Zeiss epi-fluorescent microscope, magnification 100x, scale bar = 30 µm. B – Response 
of irreversibly electroporated AT2 cells to one pulse of 400 V/cm dcEF acting locally for 
1000 ms. The cells at the end of the channel (the notch at point a in the plexiglass barrier) 
in which the electric field is focused are all dead, whereas cells outside the channel remain 
alive. Scale bar = 30 µm. C – The experiment to monitor the effect of a dcEF of 500 V/cm 
for 1000 ms focused on cells attached and spread on cover glass placed in a 10 x 3 x 1 mm 
notch (a) in a plexiglass barrier. Scale bar = 5 mm. 
 
Cell size measurement 
The sizes of spherical cells suspended in the electroporation medium were 
measured with a Coulter Z2 Cell and Particle Counter (Beckman Coulter, USA). 
The average diameter of the human red blood cells was 5.4 +/- 0.9 μm, that of 
the AT 2 rat prostate cancer cells was 14 +/- 1 μm, and that of the human skin 
fibroblasts was 18.67 +/- 2.3 μm. 
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The dcEF acting on cells can be focused and measured, as in the methods 
applied for cell electrophoresis or in the systems used for research on cell 
galvanotaxis [18-24]. With this method, strong electric fields can be localized 
and sharply separated in the designated region of the electric current circuit. The 
voltage gradient is calculated according to the Ohm law or directly measured 






Fig. 2. Experimental setup applied for cell electroporation using a localized dcEF.  
A – Photo of setup. 1 – Transverse barrier made of plexiglass with a 1-mm diameter 
orifice, through which a tube passes in which the cell suspension flows. 2 – Silicon rubber 
tube with an inserted 3-cm long segment made of dialysis membrane (3) 1 mm in diameter 
(from Sigma dialysis tubes). 4 – Power supply cords with plugs. Scale bar = 2 cm.  
B – Diagram of the cell suspension flow circuit in which cells are exposed to electric 
fields. 1 – Exchangeable plexiglass barrier (1 to 5 mm thick) with an orifice 1 mm in 
diameter, through which a tube 1 mm in diameter passes. 2 – Silicon rubber tube with a 3-cm 
long insert made of an electric current-conductive dialysis membrane of low resistance to 
ensure that the electric field was focused within the tube in its region located within the 
barrier orifice. The inflow end of the tube is connected to a needle attached to the syringe 
infusion pump; the outflow end is attached to the sample collector (Petri dishes, test tubes 
or microscope slides). 3 – A 3-cm long segment of the tube made of cellophane dialysis 
membrane. 4 – Power supply cords with plugs joined with the electrophoresis apparatus.  
5 – Probe electrodes situated either side of the barrier and joined to a Multimeter  
G-1004.500 voltmeter (RFT, Germany) to measure dcEF strength across the barrier.  
6 – The external solution in which tube is immersed. Scale bar = 1 mm. 
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performed to monitor the effect of dcEF on cells on a cover glass. Cells were 
attached and spread on a cover glass, which was placed in a 10 x 3 x 1 mm notch 
in the plexiglass barrier. All the cells within the notch were killed when exposed 
to a dcEF of 500 V/cm for 1000 ms. Cells 100 μm away from this channel 
remained alive. The thickness of the borderline between the region of the notch 
in which a strong dcEF acted on cells and the remaining low electric field area is 
limited to a few dozen micrometers, i.e. the diameter of a single cell layer (Fig. 1). 
All the other experiments were carried out with a setup permitting the controlled 
bulk flow of cells through the limited region of the channel in which the strong 
dcEF is focused, as described in the Materials and Methods section (Fig. 2). The 
duration of the flowing cells’ exposure to dcEF is determined by measuring the 
length of a sector of the channel exposed to the dcEF and the linear velocity of 
the flow of cell suspension. This corresponds to the single rectangular dcEF 
pulse applied to cells suspended in a stationary medium in disposable chambers 
attached to commercial electroporators. 
The reproducibility of the results was tested by repeating the estimation of the 
percentage of AT2 cells surviving a single exposure for 870 ms to a given dcEF 
strength acting on flowing cells. The results shown in Fig. 3 confirm the 
reproducibility of the results of identical experiments on cell irreversible 




Fig. 3. Reproducibility of results of experiments carried out with the flow through  
a localized dcEF system. AT2 prostate cancer cells were exposed for 900 ms to a dcEF in 
an electroporation medium (Ca/Mg-free PBS and 9.5% (w/w) sucrose solution in a 1:19 
ratio). The Y-axis shows the percentage of viable cells as determined with FDA-Eth BR2 
tests. The two curves represent the results of two separate experiments performed on two 
consecutive weeks. 
 
Further experiments were carried out to confirm that both types of 
electroporation, RE and in particular cell IRE (for which stronger dcEFs must be 
applied), are not associated with the thermal effect and thermal coagulation of 
proteins [25]. AT2 rat prostate cells in three solutions significantly differing in 
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electric conductivity (0.98 mS/cm, 1.92 mS/cm, 3.6 mS/cm for solutions I, II 
and III, respectively) were electroporated. The results are shown in Fig. 4. In 
these solutions, heat production at the same dcEF differs several-fold when an 
electric current is passing through the suspension. Yet the shift of the thresholds 
for IRE expressed in dcEF strength is only a few percent, probably because of 
the effects of ionic strength on the electrical stability of cell membranes [26]. 
This shows the lack of correlation between biological effects of dcEFs causing 
irreversible electroporation with heat produced by the electric current under 




Fig. 4. Results of three experiments carried out in media of different electrical conductivity 
(I – 0.98 mS/cm, II – 1.92 mS/cm, III – 3.6 mS/cm) showing no correlation between Joule 




Fig. 5. Viability of AT2 cells electroporated in the presence and absence of calcium and 
magnesium ions. Cell exposure to dcEF for 900 ms.  
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Similar observations on the lack of medium conductance influencing the 
thresholds of IRE (RE) were reported in [27], but the authors did not discuss that 
this excluded significant effects of heat production on cell electroporation 
carried out in low conductivity media. 
The presence or absence of calcium ions (when PBS with and without Ca/Mg 
was used) was found to have a very limited effect on the dependence of AT2 cell 
survival on dcEF strength at 900 ms exposure time, as shown in Fig. 5. 
Fig. 6 presents a series of curves showing that the percentage of AT2 cells 
surviving a single exposure to dcEF was dependent on dcEF strength and 
exposure time. Each curve corresponds to a different duration of cell exposure to 
dcEF and each point shows the percentage of living cells when at least 300 cells 
in the sample were counted. These results show that the dcEF strength required 
to cause IRE at a longer single exposure (in the range of 500-1000 ms) can be  




Fig. 6. Viability of AT2 cells exposed to dcEFs of different durations. Each curve corresponds 
to a different exposure time.  
 
The next series of experiments concerned RE and the uptake of dyes that do not 
penetrate the membranes of living cells. Fig. 7A, B and C respectively show the 
curves of AT2 cell survival as a function of single exposure to dcEFs of a given 
strength applied to cells for 340, 620 or 980 ms. Survival was measured by the 
uptake of ethidium bromide 15-30 min after electroporation (cf. Materials and 
Methods), showing the effectiveness of IRE together with corresponding curves 
for calcein uptake showing the effectiveness of RE. The uptake and maintenance 
of calcein AM in cells is often used as a marker of cell viability [28, 29]. The 
decline in the uptake of calcein after exceeding the optimal values of dcEF at  
a given duration of the field action corresponds therefore to an increasing 
number of cells that are unable to retain calcein. The RE is caused by much 
weaker dcEFs and/or shorter  exposure  times to dcEFs than the IRE. The curves  
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Fig. 7. Viability tested with the FDA/ethidium bromide method, and the uptake and 
maintenance of calcein in AT2 cells as a function of dcEF strength for three different times 
of cell exposure to the electric field. A – 340 ms, B – 620 ms, C – 980 ms.  
 
show that with shorter exposure times to a single dcEF action, it is easier to 
establish conditions in which a high proportion of the cells is reversibly 
electroporated and remains alive. The viability of the cells that took up the dyes 
present in the cell suspension when electroporated was additionally tested by 
seeding the electroporated cells to cell culture conditions. Electroporated cells 
under these conditions attach to the bottom of the cell culture flasks and spread 
within 2-3 h (data not shown). 
The conclusion that shorter exposure times are favorable for RE, whereas longer 
exposure times are more effective for cell killing through IRE was confirmed in 
further experiments (Fig. 8). The comparison of the effect of a single exposure to 
electric fields, causing either cell loading with calcein (RE) or cell death (IRE), 
shows that the shorter the time of exposure, the greater the difference between 
the dcEF strength required for RE and IRE. 
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Fig. 8. ED50 of the electric field strength causing 50% cell loading with calcein (lower 
curve) and 50% cell death (upper curve) as dependent upon the duration of cell exposure to 
the electric field. Numbers below the upper curve show the duration of cell exposure to the 




Fig. 9. Viability, uptake and retention of three fluorescent dyes (6-carboxyfluorescein, 
calcein and Alexa Fluor 488 Phalloidin) in AT2 cells exposed to a dcEF for 340 ms.  
 
Fig. 9 presents a series of curves showing cell viability and the uptake and 
retention of three different fluorescent dyes as dependent upon dcEF strength 
when exposed to dcEFs for 340 ms. The larger the dye molecule (in order: 
carboxyfluorescein, calcein, Alexa Fluor 488 Phalloidin), the stronger the field 
must be to induce an effective RE of cells and uptake of the tested dye. None of 
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these dyes penetrate the cell membrane of AT2 cells under standard 
experimental conditions in the cell growth media or in the electroporation 
solution. The MW of the tested dyes for carboxyfluorescein is 332.306 Da, for 
calcein is 622.55 Da, and for Alexa Fluor 488 Phalloidin is 1320 Da. When the 
dcEFs increase and reach values sufficient to cause IRE and cell death, the 
uptake of dyes gradually decreases. For smaller molecules, it is easier to find 
conditions when almost 100% of cells are reversibly electroporated (take up the 




Fig. 10. Selective IRE of cells based on their diameter. A – Loading of cells and 
maintenance of calcein as a function of dcEF acting for 620 ms on three cell types differing 
in size: human RBC (5.4 µm in diameter), AT2 prostate cancer cells (14 µm in diameter) 
and human skin fibroblasts (HSF; 18.7 µm in diameter). B – The same curves but with 
dcEF strength expressed as a voltage gradient per cell diameter. 
 
It was reported that IRE can be applied to eliminate and kill cells with diameters 
greater than a selected size threshold [30, 31]. Subsequent experiments were 
therefore performed to examine whether the method applied in our experiments 
can be useful for this purpose. The RE of viable cells and IRE when calcein is no 
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longer kept in the cells were estimated for human skin fibroblasts (HSF) of 
18.67 +/- 2.3 μm in diameter, AT2 cells of 14 +/- 1 μm in diameter, and red 
blood cells (RBC) of 5.4 +/- 0.9 μm in diameter. The cells were given a single 
exposure to dcEF for 340 ms. The results are shown in Fig. 10A. Much stronger 
dcEFs were required for both RE and IRE of RBC than for AT2 cells. The ED50 for 
RBC was 966.7 V/cm, for AT2 cells was 194 V/cm and for HSF was 35.9 V/cm. 
LD50 for IRE was 1204 V/cm for RBC, 784 V/cm for AT2 cells and 525.9 V/cm for 
HSF. When these values were normalized to the cell diameter, they corresponded to 
dcEF values causing 50% RE, as shown in Fig. 10B. The values expressed as 
dcEF/cell diameter are: 0.53 V/cell for RBC, 0.27 V/cell for AT2 cells, and  
0.07 V/cell diameter for HSF. LD50 was: 0.7 V/cell for RBC, 1.1 V/cell for AT2 




Our results show that the described method of electroporation of cell 
suspensions exposed to a short localized dcEF is very versatile. It permits the 
adjustment and control of the strength of the electric field and time of its action 
on flowing cells. In addition, the described system is based on the use of 
standard laboratory equipment. 
The results concerning cell viability and cell loading with cell membrane non-
permeable substances are reproducible and the method can be used for 
electroporation of small volumes of cell suspensions (0.1 ml) as well as for large 
suspension volumes (5-10 ml). The dcEF strength acting locally on flowing cells 
can be regulated in the range of 0-2000 V/cm and the duration of exposure of the 
flowing cells to the dcEFs can be adjusted in the range of one to a few thousand ms. 
The experiments were limited to the effects of a single exposure of cells to 
dcEFs of known strength and duration. We studied the influence of the duration 
of AT2 cell exposure to dcEFs of variable strength upon cell survival (IRE) 
and/or upon reversible perforation (RE) and cell loading with membrane non-
permeable substances (fluorescent dyes). We found that for IRE, it is favorable 
to use relatively long lasting (500-1500 ms) cell exposure times to dcEFs. 
External dcEFs acting on suspended cells influence the cell membrane as  
a primary target [32, 33]. The cell interior, nucleus, mitochondria and other 
organelles within the cell remain screened from the externally acting dcEFs. 
However, when the dcEF acts on the cells for a longer time (i.e. milliseconds), 
pores appear within the first phase of the cell exposure to dcEF. As a consequence, 
the electric field can later act within the cells and its effects are no longer limited 
to the cell membranes. The process of pore formation is very fast, but the pores 
remain open for much longer, depending on temperature [34-37]. Thus, once the 
pores are formed, the ionic current begins to flow through the cytoplasm and the 
dc electric field begins to act within the cell interior on the nucleus and 
cytoplasmic structures. Cell death due to IRE, in particular with longer exposure 
times (in the range of dozens and hundreds of milliseconds) or when cells are 
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subjected to a series of electric pulses, for example of 100 ms duration, can 
therefore also depend on the electric field acting within the cells alongside its 
effects on the cell membrane. This might be similar to exposure of cells to ns 
pulses, which directly act on the nucleus and cytoplasm [38-40]. This question 
requires a separate set of experiments to be unequivocally answered.  
The conditions under which flowing cell suspensions are reversibly 
electroporated are more favorable to cells than when the cells are electroporated 
within electroporation chambers. Aluminum or stainless steel electrodes are 
generally mounted in the conventionally used disposable electroporation 
chambers [10]. Such electrodes polarize, causing the dcEFs, applied as 
rectangular pulses in the solution, to change shape with time. Polarizable 
electrodes also cause gas bubble formation, which can disturb the distribution of 
the dcEF within the chamber and may injure the cells. Because ions are 
characterized by high electrokinetic mobility, the dcEF can induce local changes 
in pH and ion concentration near the surface of the electrodes. These 
inconveniences are absent when cells flow through a locally focused electric field.  
The exposure of cells located in a narrow canal in which dcEFs are focused was 
also recently tested [41]. The authors used needle steel electrodes and this led to 
issues associated with the appearance of gas bubbles. These bubbles disturbed 
the electric field and caused cell injury. The authors therefore concluded that 
dcEFs are not suitable for electroporation of cells located in the narrow channel 
between electrodes. To avoid these difficulties, they applied pulses of alternate 
polarity. Similar difficulties were found years ago when stainless steel or 
aluminum polarizable electrodes were tested in research into cell electrophoresis 
or cell galvanotaxis. Such difficulties in research on cell electophoresis or cell 
galvanotaxis were avoided by the use of reversible Ag/AgCl electrodes, and 
often by additional separation of electrodes with agar bridges from the chambers 
or capillaries containing the cells. In the same cases, the effects of electrode 
products upon cells were eliminated by focusing the dcEF at a significant 
distance from the surface of the electrodes [12, 18-22].  
The cell flow system for electroporation that we used is similar to that used in 
experiments on cell electrophoresis and cell galvanotaxis [12, 23]. The dcEF was 
focused about 12 cm from the electrodes of the electrophoresis apparatus, and 
flowing cells were separated from the electrode-containing solution by a dialysis 
membrane. In some experiments, reversible Ag/AgCl electrodes were also used, 
but this did not change the results. The protection of cells from the harmful 
effects of electrode products and good heat dispersion in our experiments could 
be the reason why high percentages of cells were reversibly electroporated, 
preserving over 90% cell viability, which is much higher than usually reported in 
experiments with conventional electroporators.  
In summary, the results of our experiments with the flow of cell suspensions 
through localized dcEFs have shown that: 
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1. Experiments with such a system would be easier than those with commercial 
electroporators, and researchers could more precisely control experimental 
conditions. 
2. The system can be used for RE and loading of large volumes of cell 
suspensions with cell membrane non-permeable substances. In the case of 
loading cells with vital fluorescent dyes it can replace the need for expensive 
derivatives of the dyes (AM calcein, BCECF, etc.). 
3. The use of electrodes that are separated from the cells protects the cells 
against harmful electrode products and permits the preservation of good 
viability of electroporated cells, to over 90% when RE is performed. 
4. The decrease in Joule (Ohmic) heating of the cell suspension thanks to low-
electric conductivity media and good heat dispersion confirmed that RE and 
IRE are not related to cell heating [22, 27, 42, 43]. 
5. The estimation of strength-duration curves for RE and IRE shows that a 
strong dcEF acting for a short time is favorable for RE, whereas longer 
action times and weaker dcEFs are effective for cell killing by IRE. It is 
easier to ensure conditions for a high percentage of cell loading with 
membrane non-permeable molecules. More than 90% of cells survive this 
procedure using a single dcEF action on flowing cells for less than 100 ms. 
On the other hand, for IRE, a longer exposure time was more efficient than 
for short ones. 
6. The efficiency of RE and IRE strongly depends upon the size of the cells 
exposed to dcEFs; the differences in dcEF strength and duration causing RE 
and IRE of different cells depend not only on differences in the physical and 
chemical properties of the cell membranes but correlates with cell diameters 
and cell surface curvature [30, 44-48]. With the described method, it is easy 
to selectively kill cells of greater size than required in great cell suspension 
volumes, i.e. to obtain results similar to subjecting flowing cells to a series 
of rectangular electric pulses [30]. 
The described method of cell electroporation by short exposure of flowing cell 
suspensions to localized dcEFs can be used to search for improved conditions 
for RE and IRE experiments in vivo. The method can be applied for many 
purposes, e.g. for the introduction of membrane impermeable compounds to 
large amounts of cells, for the elimination of cells of size greater than required 
from mixed cell suspensions, or for the exact determination of parameters of the 
dcEF acting on cells. We believe that the conclusions from the results of in vitro 
experiments can be useful for planning the optimal conditions for in vivo clinical 
use of both RE and IRE. 
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